Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...

An innovative stem cell therapy approved for severe heart failure has been cleared for use in Japan. Here is why it matters ...

What you need to know The prevalence of heart failure across Europe is estimated to be 1-2% of adults.1 In the UK, this places a substantial burden on patients and healthcare resources, including ...

Updated NICE guidance introduces important developments, but evidence and implementation gaps remain Since the publication of the 2018 National Institute for Health and Care Excellence (NICE) ...

Strict sodium intake — with or without restrictions on fluid intake — is unlikely to confer clinical benefits on patients with heart failure, reported investigators. Their review of studies showed ...

Middle aged and older adults who are hospitalized for severe infections were more than twice as likely to develop heart failure in the future, a new study shows. Authors say that’s why it’s so ...

Waist-to-hip ratio is another belly fat measure, which may predict heart attack risk better than BMI, especially in women, ...

If you cut your arm or undergo surgery, scarring can be a good thing; the scar tissue produced by cells called fibroblasts helps you heal. In most organs of the body, however, the accumulation of ...

Your kidneys and heart are closely connected, and CKD can increase your risk of heart issues. Learn how to notice signs of problems and potential treatments.

Every few years, American politics rediscovers chronic disease. Leaders point to rising rates of diabetes, heart disease and depression. They say people are sicker because they eat the wrong food, ...

Some people with heart failure need to take multiple medicines each day to keep their symptoms under control. Heart failure is a chronic, or long-term, condition. It can lead to issues not only in the ...

Beta blockers have been shown to prolong survival in chronic heart failure. It is currently a matter of debate whether any β blocker is superior to the other in terms of improving symptoms, left ...